Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
Healthy Volunteers
NCT05120635

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

Led by Duke University · Updated on 2025-12-16

80

Participants Needed

2

Research Sites

247 weeks

Total Duration

On this page

Sponsors

D

Duke University

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Anxiety disorders such as post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD) affect a large number of individuals with a significant portion of patients failing to improve with current treatments. The purpose of this study is to understand the brain mechanisms that produce fear and anxiety in humans. To accomplish this goal, we will measure the brain activity along with the heart rate and skin perspiration of patients while they are completing tasks on a computer. Some of the tasks will also use a virtual reality headset and transport the patient in a video game-like environment. These tasks will expose the participants to various levels of fear-provoking images. Participants with responsive neurostimulation (RNS) implants will be enrolled under Pro00117931 at Duke, but their results for fear and anxiety tasks will be reported under NCT05120635.

CONDITIONS

Official Title

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

Who Can Participate

Age: 18Years - 70Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Has undergone acute depth or chronic responsive neurostimulation (RNS) electrode placement
  • Willing to provide informed consent and participate in the study
  • Ability to read and write English fluently
Not Eligible

You will not qualify if you...

  • Unwilling to provide informed consent
  • Has not undergone acute depth or chronic responsive neurostimulation (RNS) electrode placement
  • Pregnant women
  • Participants with active psychosis
  • Participants with suicidal ideation
  • Participants with substance abuse issues

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of California Los Angeles

Los Angeles, California, United States, 90024

Actively Recruiting

2

Duke University Health System

Durham, North Carolina, United States, 27705

Actively Recruiting

Loading map...

Research Team

G

Gabriela Vilchez

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here